Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Paul W. Armstrong; Burkert Pieske; Kevin J. Anstrom; Justin A. Ezekowitz; Adrian F. Hernandez; Javed Butler; Carolyn S.P. Lam; Piotr Ponikowski; Adriaan A. Voors; Gang Jia; Steven E. McNulty; Mahesh J. Patel; Lothar Roessig; Joerg Koglin; Christopher M. O’Connor

doi:10.1056/nejmoa1915928

Abstract

Among patients with high-risk heart failure, the incidence of death from cardiovascular causes or hospitalization for heart failure was lower among those who received vericiguat than those who received placebo.

Keywords

Ejection fractionHeart failureCardiologyFraction (chemistry)Internal medicineMedicineChemistry

Affiliated Institutions

Related Publications

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray , Scott D. Solomon , Silvio E. Inzucchi +35 more

BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...

2019 New England Journal of Medicine 6238 citations

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer , Stefan D. Anker , Javed Butler +36 more

Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...

2020 New England Journal of Medicine 4558 citations

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker , Javed Butler , Gerasimos Filippatos +38 more

Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless...

2021 New England Journal of Medicine 4054 citations

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon , John J.V. McMurray , Brian Claggett +39 more

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction....

2022 New England Journal of Medicine 2231 citations

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

Salim Yusuf , Bertram Pitt , C.E. Davis +2 more

The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates ...

1992 New England Journal of Medicine 3728 citations

Publication Info

Year: 2020
Type: article
Volume: 382
Issue: 20
Pages: 1883-1893
Citations: 1170
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1170

OpenAlex

Cite This

APA Style

                            
                                
                                    Paul W. Armstrong, 
                                
                                    Burkert Pieske, 
                                
                                    Kevin J. Anstrom
                                
                                et al.
                            
                            (2020). 
                            Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. 
                            New England Journal of Medicine
                            , 382
                            (20)
                            , 1883-1893.
                            https://doi.org/10.1056/nejmoa1915928
                        

Identifiers

DOI: 10.1056/nejmoa1915928